IOVS Circulation
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

(Investigative Ophthalmology and Visual Science. 2003;44:3866-3872.)
© 2003 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.03-0223
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McLoon, L. K.
Right arrow Articles by Christiansen, S. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McLoon, L. K.
Right arrow Articles by Christiansen, S. P.

Increasing Extraocular Muscle Strength with Insulin-like Growth Factor II

Linda K. McLoon and Stephen P. Christiansen

From the Department of Ophthalmology, University of Minnesota, Minneapolis, Minnesota.

PURPOSE. Botulinum toxin type A and, more recently, the immunotoxin ricin-mAb35 have been effective as means of pharmacologically weakening the extraocular muscle. However, currently there are no drug treatments to strengthen an underacting extraocular muscle. In limb muscle, treatment with insulin-like growth factor causes myofiber hypertrophy. In this study, the short-term effects of insulin-like growth factor II (IGF-II) on extraocular muscle morphometry and force generation were examined.

METHODS. One superior rectus muscle in normal adult rabbits received a single injection of 10 µg IGF-II, and the contralateral muscle received an injection of saline only. One week after injection, muscle morphology and muscle force were compared between the IGF-treated and control muscles.

RESULTS. In the treated muscle, there was no significant change in the mean cross-sectional area of myofibers compared with the control. However, there was an increase in the heterogeneity of myofiber cross-sectional area, with increases in both small and very large myofibers. Mean single-twitch force generation was 0.48 ± 0.12 mN/cm3 compared with 0.27 ± 0.04 mN/cm3 (P = 0.0473) in control samples. Mean tetanic force generation was increased significantly at all stimulation frequencies. Treatment had no effect on muscle fatigability.

CONCLUSIONS. Extraocular muscle is very responsive to direct injection of IGF-II. Although no difference was seen in mean myofiber cross-sectional area, overall there was sufficient alteration in myofiber heterogeneity to result in increased force generation. If a sustained treatment effect can be achieved with IGF-II and, potentially, other growth factors, the pharmacological treatment of strabismus could be advanced by simultaneous injection of agonist–antagonist pairs with agents that weaken and strengthen the treated extraocular muscle.




This article has been cited by other articles:


Home page
 IOVSHome page
R. S. Antunes-Foschini, D. Miyashita, H. E. A. Bicas, and L. K. McLoon
Activated Satellite Cells in Medial Rectus Muscles of Patients with Strabismus
Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 215 - 220.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
B. C. Anderson, S. P. Christiansen, and L. K. McLoon
Myogenic Growth Factors Can Decrease Extraocular Muscle Force Generation: A Potential Biological Approach to the Treatment of Strabismus
Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 221 - 229.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
J. M. Devaney, E. P. Hoffman, H. Gordish-Dressman, A. Kearns, E. Zambraski, and P. M. Clarkson
IGF-II gene region polymorphisms related to exertional muscle damage
J Appl Physiol, May 1, 2007; 102(5): 1815 - 1823.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
R. M. S. Antunes-Foschini, F. S. Ramalho, L. N. Z. Ramalho, and H. E. A. Bicas
Increased frequency of activated satellite cells in overacting inferior oblique muscles from humans.
Invest. Ophthalmol. Vis. Sci., August 1, 2006; 47(8): 3360 - 3365.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
B. C. Anderson, S. P. Christiansen, S. Grandt, R. W. Grange, and L. K. McLoon
Increased Extraocular Muscle Strength with Direct Injection of Insulin-like Growth Factor-I.
Invest. Ophthalmol. Vis. Sci., June 1, 2006; 47(6): 2461 - 2467.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
S. P. Christiansen and L. K. McLoon
The Effect of Resection on Satellite Cell Activity in Rabbit Extraocular Muscle
Invest. Ophthalmol. Vis. Sci., February 1, 2006; 47(2): 605 - 613.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
S. N. Mehiri, E. Barreiro, M. Hayot, M. Voyer, A. S. Comtois, A. E. Grassino, and G. Czaika
Time-based gene expression programme following diaphragm injury in a rat model
Eur. Respir. J., March 1, 2005; 25(3): 422 - 430.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
J. Chen and C. S. von Bartheld
Role of Exogenous and Endogenous Trophic Factors in the Regulation of Extraocular Muscle Strength during Development
Invest. Ophthalmol. Vis. Sci., October 1, 2004; 45(10): 3538 - 3545.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the Association for Research in Vision and Ophthalmology